Celgene Corporation to Webcast at Upcoming Investor Conferences
Celgene Corporation (NASDAQ:CELG) plans to present at four upcoming investor conferences where Celgene management will provide
an overview of the Company. The conferences will be webcast live and will be available in the Investor Relations section of the
Company’s website at www.celgene.com.
Wednesday, September 6, 2017, Celgene will present at the Baird Global Healthcare Conference in New York City
at 3:45 pm ET
Wednesday, September 13, 2017, Celgene will present at the Morgan Stanley Global Healthcare Unplugged
Conference in New York City at 9:20 am ET
Thursday, September 14, 2017, Celgene will present at the Bank of America Merrill Lynch Global Healthcare
Conference in London at 11:10 am ET
Tuesday, September 26, 2017, Celgene will present at the Cantor Fitzgerald 3rd Annual Healthcare Conference
in New York City at 9:45 am ET
About Celgene
Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in
the discovery, development and commercialization of innovative therapies for the treatment of cancer and inflammatory diseases
through next-generation solutions in protein homeostasis, immuno-oncology, epigenetics, immunology and neuro-inflammation. For more
information, please visit www.celgene.com. Follow Celgene on Social Media: @Celgene, Pinterest, LinkedIn, Facebook and YouTube.
Forward-Looking Statements
This press release contains forward-looking statements, which are generally statements that are not historical facts.
Forward-looking statements can be identified by the words "expects," "anticipates," "believes," "intends," "estimates," "plans,"
"will," “outlook” and similar expressions. Forward-looking statements are based on management’s current plans, estimates,
assumptions and projections, and speak only as of the date they are made. We undertake no obligation to update any forward-looking
statement in light of new information or future events, except as otherwise required by law. Forward-looking statements involve
inherent risks and uncertainties, most of which are difficult to predict and are generally beyond our control. Actual results or
outcomes may differ materially from those implied by the forward-looking statements as a result of the impact of a number of
factors, many of which are discussed in more detail in our Annual Report on Form 10-K and our other reports filed with the
Securities and Exchange Commission.
Hyperlinks are provided as a convenience and for informational purposes only. Celgene bears no responsibility for the
security or content of external websites.
Celgene Corporation
Patrick E. Flanigan III, 908-673-9969
Corporate VP, Investor Relations
or
Celgene Corporation
Brian Gill, 908-673-9530
VP, Corporate Communications
View source version on businesswire.com: http://www.businesswire.com/news/home/20170824005564/en/